Dementia care is one of the critical issues facing the aged care industry. About 500,000 Australians currently live with the brain disorder condition, and this is tipped to rise to 1.1 million in a generation.
How to effectively provide quality care for people living with dementia was a key element of the royal commission into aged care, which found the complex care required was an ongoing challenge for the industry.
More than half the residents in aged care homes have a diagnosis of dementia. “We are deeply concerned that so many aged care providers do not seem to have the skills and capacity required to care adequately for people living with dementia,” the final report said.
To address these skills gaps, Dementia Australia, developed two applications to help with the learning and development of carers. Australian Health Journal spoke with Dr Tanya Petrovich, Dementia Australia’s Business Innovation Manager on how these platforms help those caring for people with dementia to understand, and improve their communication with people experiencing dementia. Tanya also spoke about last year Dementia Australia winning two Future of Ageing Awards in the Dementia Care and Business Technology categories.
Winner of Dementia Care category in the 2022 Future of Ageing Awards: Talk with Ted
The Talk With Ted program, created by Dementia Australia, simulates a typical chat including emotional and verbal responses between a carer and the resident.
“This type of experiential learning, that is both engaging and innovative, helps people to recall exactly what they’ve learned and makes them more likely to implement these new skills – which means better care for our loved ones living with dementia,” said Dementia Australia’s CEO Maree McCabe at the time of the launch.
The AI platform was created through a collaboration between Dementia Australia’s Centre for Dementia Learning and Deakin University’s Applied Artificial Intelligence Institute (A²I²), care workers, and was informed by real-life experiences of people living with dementia. Funding came from the Rosemary Norman Foundation.
Winner of Business Technology category in the 2022 Future of Ageing Awards: Ask Annie
There are more than 130,000 people working in-home support and community care across Australia. These people play a vital role for people living with dementia, their families, and carers.
‘Ask Annie’ is a virtual tool for community care workers providing dementia care in the home. Annie guides users through a range of scenarios, based on real-life experiences, to strengthen their dementia care skills.
The mobile app offers short, self-paced learning modules to help care workers refresh their skills and learn tips and tools to provide better care to people living with dementia. These are referred to as micro-learning training, that is accessible whenever a care worker wants to schedule a quick 10 or 15-minute lesson.
Ask Annie was developed by Dementia Australia with Deakin University’s Applied Artificial Intelligence Institute (A²I²), with the financial support of Gandel Philanthropy.
Produced with kind assistance from Inside Ageing and Future of Ageing Awards.
-
Taiwanese health and research delegation visit Paratus clinical trial site in Canberra
In late August 2025, a Taiwanese delegation comprising government officials from the Taiwanese FDA, various governmental groups, and physicians and researchers from across Taiwan, visited Paratus Clinical’s trial site in Canberra. Their objective was to explore both the differences and similarities between the clinical research ecosystems of Taiwan and Australia.
-
New treatment options under investigation for pelvic organ prolapse
Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.
-
Improved access to technology needed for people with Type 2 Diabetes needing insulin
The National Diabetes Services Scheme (NDSS) provides subsidised products for diabetes management; however, disparities exist in access to technology between those with Type 1 and Type 2 diabetes. While continuous glucose monitoring (CGM) devices are subsidised for Type 1, they are not available for Type 2 diabetes. ADEA advocates for equitable access to these essential tools, emphasising that all individuals with diabetes deserve the resources necessary for optimal management and reduced risk of complications. Without such technologies, many are forced to rely on finger pricking, which can be inconvenient and unsafe in settings such as the workplace and in higher education.
